Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells

Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells

US Patent 8765119 · Granted Jul 1, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Plasma derived from human umbilical cord blood for the treatment of neurodegener2024
Plasma derived from human umbilical cord blood for the treatment of neurodegener2024
Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-2023
Plasma derived from human umbilical cord blood for the treatment of neurodegener2023
Plasma derived from human umbilical cord blood for the treatment of neurodegener2023
Compositions and methods for the treatment of demyelinating conditions2022
Plasma derived from human umbilical cord blood for the treatment of neurodegener2021
Plasma derived from human umbilical cord blood for the treatment of neurodegener2021
Method of stem cell delivery into the brain during chronic disease using blood b2020
Ischemic tissue cell therapy2019
Ischemic tissue cell therapy2019
Non-invasive method for direct delivery of therapeutics to the spinal cord in th2019